Clarifying off-target effects for torcetrapib using network pharmacology and reverse docking approach.
about
Nimbolide targets BCL2 and induces apoptosis in preclinical models of Waldenströms macroglobulinemia.Layered signaling regulatory networks analysis of gene expression involved in malignant tumorigenesis of non-resolving ulcerative colitis via integration of cross-study microarray profiles.Clarifying the molecular mechanism associated with carfilzomib resistance in human multiple myeloma using microarray gene expression profile and genetic interaction networkIn silico methods for drug repurposing and pharmacologyBisdemethoxycurcumin exerts pro-apoptotic effects in human pancreatic adenocarcinoma cells through mitochondrial dysfunction and a GRP78-dependent pathway.Reverse docking: a powerful tool for drug repositioning and drug rescue.Looking into the crystal ball-upcoming drugs for dyslipidemia.Development of broad-spectrum antibiofilm drugs: strategies and challenges.SNP mutations occurring in thyroid hormone receptor influenced individual susceptibility to triiodothyronine: Molecular dynamics and site-directed mutagenesis approaches.Reverse Screening Methods to Search for the Protein Targets of Chemopreventive Compounds.Exploring the molecular mechanism associated with breast cancer bone metastasis using bioinformatic analysis and microarray genetic interaction networkMolecular pathogenesis involved in human idiopathic pulmonary fibrosis based on an integrated microRNA‑mRNA interaction network
P2860
Q30848149-D6CBEC75-AD26-4C83-8D47-47AD7D8AD939Q34794766-95118D0C-851B-4B82-BF6A-438F9A6BB06CQ36303485-B92BF321-2E96-454D-9051-1468C83B6BA3Q36837816-662EA519-C489-4BD5-ABD5-96A71E0C08F4Q37696356-5ED51A42-1EF8-4A65-8B47-D62577E5FBD9Q38191684-E14A0564-81AF-4D20-A6C5-5F9A9348AD54Q38235611-54938E3E-86A6-4C62-8EF1-0313E4471FB7Q38522806-BFEC954D-6A3D-4055-A3A3-2B42638AE620Q47662684-B0D2F744-099D-4E09-92F1-EC2DA12F5BBAQ55093753-BE2D0552-1306-4686-BCD4-99A9BE79174CQ58739441-4D4B4807-54BC-49B2-9806-757429156F51Q58762351-3198D4F5-C056-41E6-8633-B2314FC52389
P2860
Clarifying off-target effects for torcetrapib using network pharmacology and reverse docking approach.
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Clarifying off-target effects ...... and reverse docking approach.
@ast
Clarifying off-target effects ...... and reverse docking approach.
@en
Clarifying off-target effects ...... and reverse docking approach.
@nl
type
label
Clarifying off-target effects ...... and reverse docking approach.
@ast
Clarifying off-target effects ...... and reverse docking approach.
@en
Clarifying off-target effects ...... and reverse docking approach.
@nl
prefLabel
Clarifying off-target effects ...... and reverse docking approach.
@ast
Clarifying off-target effects ...... and reverse docking approach.
@en
Clarifying off-target effects ...... and reverse docking approach.
@nl
P2093
P2860
P356
P1433
P1476
Clarifying off-target effects ...... and reverse docking approach.
@en
P2093
Qiang Geng
Shengjun Fan
Zhenyu Pan
P2860
P2888
P356
10.1186/1752-0509-6-152
P577
2012-12-10T00:00:00Z
P5875
P6179
1032304584